National Pharmacy Health & Leadership Alliance Verify a MemberMember Login
NPHLANational Pharmacy Health & Leadership Alliance
Apply for Membership

NPHLA Intelligence

The Signal Board

What is moving: topics ranked by the attention they are drawing across official records, research and industry reporting over the last day and week. Strength describes editorial attention, never medical certainty or the strength of evidence.

All desks

Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.

  1. Diabetes developments15 tracked items this week · 7 sources
    High attention
  2. Semaglutide13 tracked items this week · 5 sources
    High attention
  3. AI in healthcare8 tracked items this week · 5 sources
    Building
  4. Exosomes4 tracked items this week · 4 sources
    Building
  5. Orforglipron3 tracked items this week · 3 sources
    Emerging
  6. Tirzepatide9 tracked items this week · 5 sources
    Building
  7. Obesity drug pipeline4 tracked items this week · 3 sources
    Building
  8. Lean mass & body composition3 tracked items this week · 3 sources
    Emerging
  9. Hair restoration5 tracked items this week · 3 sources
    Building
  10. Oral GLP-1 therapies2 tracked items this week · 2 sources
    Emerging
  11. Hormonal health & BHRT2 tracked items this week · 2 sources
    Emerging
  12. Patient communications & voice AI2 tracked items this week · 2 sources
    Emerging
  13. Retatrutide4 tracked items this week · 3 sources
    Building
  14. Amylin-based therapies4 tracked items this week · 3 sources
    Building
  15. FDA enforcement & warning letters3 tracked items this week · 3 sources
    Emerging

Metabolic

Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.

  1. Diabetes developments
  2. Semaglutide
  3. Orforglipron
  4. Tirzepatide
  5. Obesity drug pipeline
  6. Lean mass & body composition

Regulatory

Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.

  1. Semaglutide
  2. Tirzepatide
  3. Hormonal health & BHRT
  4. FDA enforcement & warning letters
  5. PBMs & reimbursement
  6. State boards of pharmacy

Aesthetics & Longevity

Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.

  1. Exosomes
  2. Lean mass & body composition
  3. Hair restoration
  4. Hormonal health & BHRT
  5. Energy-based aesthetic devices
  6. Counterfeit & unapproved products

AI & Technology

Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.

  1. AI in healthcare
  2. Patient communications & voice AI
  3. PBMs & reimbursement
  4. Practice growth & operations
  5. Telehealth technology
  6. Telehealth prescribing & medication delivery